Yahoo India Web Search

Search results

  1. 2 days ago · Natco Pharma Share Price Today (27 Sep, 2024): Natco Pharma Stock Price (₹ 1413.15) Live NSE/BSE updates on The Economic Times. Check out why Natco Pharma share price is up today. Get all details on Natco Pharma Ltd.shares news and analysis, Forecasts, Dividend, balance sheet, profit & loss, Quarterly results, annual report information, and more

  2. Apr 30, 2024 · The company witnessed revenue growth of 39.2% in FY2023, backed by substantial profit share contribution from gRevlimid and gCopaxone and improvement in performance of its Canadian and Brazilian subsidiaries. In 9M FY2024, the company witnessed robust YoY revenue growth of 62.0% driven by growth across segments

  3. Natco Pharma Limited (NATCO) is a vertically integrated pharmaceutical company with a strong focus on R&D. Our expertise lies in the development, manufacturing and commercialisation of

  4. Natco Pharma Profit and Loss. BSE: 524816 | NSE: NATCOPHARMEQ | IND: Pharma - Indian | ISIN code: INE987B01026 | SECT: Pharmaceuticals. The P&L A/C page of Natco Pharma Ltd. presents the key P&L A/c Ratios, its comparison with the sector peers and 5 years of Profit & Loss Account Statement. STANDALONE DATA. Total Income. 50.77 % Rs 3,673.60Cr.

  5. The ratings reaffirmation considers Natco Pharma Limiteds (Natco/the company) healthy abbreviated new drug application (ANDA) portfolio in the complex generics space in the US market complemented by its strong research and development (R&D) capabilities.

  6. Introduction to NATCO Pharma FIGHTING THE PANDEMIC WITH LONG-TERM FOCUS INTACT NATCO Pharma Limited (NATCO) is a vertically integrated, R&D-focused pharmaceutical company that specialises in the development, manufacture and commercialisation of complex pharmaceuticals catering to niche therapeutic areas.

  7. People also ask

  8. Feb 15, 2024 · Natco Pharma declared their Q3 FY24 results on 14 Feb, 2024. The topline increased by 54.03% & the profit increased by 241.41% YoY. As compared to the previous quarter the revenue declined by...